4/A: Charles River Laboratories Executive Knell Reports Stock Transactions

Michael Gunnar Knell, CSVP & Chief Accounting Officer of Charles River Laboratories, reports the acquisition and disposal of common stock on March 8, 2024, according to a Form 4/A filing.

Summary

• Michael Gunnar Knell, CSVP & Chief Accounting Officer of Charles River Laboratories International, Inc., filed a Form 4/A with the SEC.
• The report details changes in beneficial ownership of the company's common stock.
• On March 8, 2024, Knell acquired 808 shares of common stock through the exercise of stock options at a price of $267.52 per share.
• On the same day, Knell disposed of 808 shares of common stock at a price of $267.52 per share.
• Following these transactions, Knell directly owns 7,825 shares of Charles River Laboratories common stock.
• Knell also owns 404 derivative securities (stock options).

Sentiment

Score: 5

Explanation: The document is a standard SEC filing detailing stock transactions, with neutral sentiment.

Industry Context

This filing is a routine disclosure of stock transactions by a company insider, which is common in publicly traded companies. It provides transparency into the trading activities of key personnel.

Stakeholder Impact

• The stock transactions may have a minor impact on shareholders, as insider trading activity is often monitored for signals about company performance.

Key Dates